My pleasure to join the 6th International Congress of Nephrologists in Shaoxing. Good to meet old+ new friends and share my thoughts on registry data and glucose monitoring in dialysis 😇😁
#ICCN2026@CUHKMedicine
Big ideas. Global impact. 🌱
🌟Proud to be part of the ISN Young Nephrologists Committee, empowering the next generation for kidney health worldwide — our journey featured in Kidney International 🚀
#ISNyoung
Thank you for the positive feedback from our experts and young fellows in the ‘Meet the Professors’ session in #APCN2025. An amazing session filled with science and life philosophy🤓
Thanks to the organising committee #ASNYNC 🤣🤣 good to meet all of you again 😇
@Apsn_eph
World Congress of Nephrology 2026 - March 28–31, 2026 at PACIFICO Yokohama, Latest advancements in global kidney health, featuring internationally recognized experts, interactive sessions, and networking opportunities! @ISN@APSN @WCN26 @nephrology@ISNkidneycare@apsneph
Enjoyed the first visit to ZhengZhou😁
Thank you for the opportunity to share my thoughts (in Putonghua😅) on glycemic monitoring in dialysis patients in #CCSN2025
Also enjoyed great food with great friends from #HKSN 😊
Decongestion is important for both heart and kidney! Excited to be the moderator of the lecture by my good friend Prof G Tan, who enlightens us on the use of tolvaptan on heart failure 🤩🥳
#EastMeetWest#CKMbuddies@CUHKMedicine
Very fruitful APSN-HKSN CME course 😊😊 inspiring talk on AKI biomarker and sepsis-induced AKI by Prof Desmond Yap and Prof Kornchanok @KVploy 🤩
Look forward to APCN 2025 @Apsn_eph in Taiwan!
#APSNYNC
Thrilled and honored to share volume management and CGM in #ISPDAPCM25 🥳
Good to catch up with my good friends @KVploy and Lydia and I-Ru
See you again in Taiwan #APCN25 🤩
#APSNYNC@ISPD1
Thrilled to complete three focus oral presentation about effect of SGLT2i on podocytes, and effect of PPI on risk of PD-associated peritonitis in #ERA25
😃
Excited to witness the release of CONFIDENCE trial and listen to excellent performance by orchestra in Golden Hall 😍
Fantastic to see CONFIDENCE trial results presented at #ERA25 and in @NEJM
Prevention of CV events, esp. heart failure, is probably most compelling rationale for rapid initiation of combo therapy in CKD/T2D, with benefits on kidney failure accruing gradually over time
The findings of this study highlight the substantial and growing Cardiovascular-Kidney-Metabolic (CKM) syndrome-related burden, emphasizing the urgent need for comprehensive and targeted interventions. https://t.co/tsBouSMQic
#ASNJASN
Excited to give a talk about nsMRA on diabetic kidney disease using local data, followed by interesting panel discussion 🤩 And my pleasure to be the MC of HKSN 45th Anniversary Dinner 😝
#ICCN2024
Kick-starting the 5th International Congress of Chinese Nephrologists 2024🥳🤩 Fascinating opening ceremony and plenary lecture by Prof Philip Li🤩
#ICCN2024#PD2025
Our invited viewpoint on #GLP1ra : The emerging fourth pillar in #t2d and #CKD?
In #FLOW, once weekly semaglutide reduced kidney endpoints by 24% with a projected delay to need for RRT by 5 yrs.
Free link
https://t.co/ATVOA7c6xq